Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-046519

CEO and President acquired 3,990 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szela Mary T CEO and President 2026-06-30 Grant or award +3,990 $3.87 $15,441 1,077,683 D
Loading xslF345X06/wk-form4_1782936285.xml…